Described herein are methods, devices, and systems for providing an implantable leadless pacemaker (LP) with a remote follow-up capability whereby the LP can provide diagnostic information to an external device that is incapable of programming the LP, wherein the LP includes two or more implantable electrodes used to output both pacing pulses and conductive communication pulses. Such a method can include the LP monitoring for a presence of one or more notification conditions associated with the LP and/or associated with a patient within which the LP is implanted, and the LP periodically outputting an advertisement sequence of pulses, using at least implantable electrodes of the LP, irrespective of whether the LP recognizes the presence of at least one notification condition. The method can also include the LP recognizing the presence of at least one notification condition, and based thereon, the LP also outputting a notification sequence of pulses.

A method and apparatus to deliver electrical stimulation using wireless controlled neuromuscular electrical stimulation devices are disclosed. The electrical neuromuscular stimulation device allows the delivery of short electrical impulses triggered and controlled by transmitters directed towards a receiver. The proposed method and apparatus may enable the recreation of realistic haptic sensory feedback. Possible uses include, but are not limited to gaming, entertainment, learning, training, medical, rehabilitation, and educational purposes.

Methods and systems can facilitate identifying effective electrodes and other stimulation parameters, as well as determining whether to use cathodic and anodic stimulation. Alternately, the methods and systems may identify effective electrodes and other stimulation parameters based on preferential stimulation of different types of neural elements. These methods and systems can further facilitate programming an electrical stimulation system for stimulating patient tissue.

An invention and method that generate dynamical shaped voltage-gradient geometries through a plurality of dual-modal electrode-contacts placed around the biological tissue in vivo. The geometry of the voltage gradient is optimized through a feedback mechanism from the plurality of dual-modal electrode-contacts that can record electric and magnetic field potentials in the biological tissue. A control controls the waveform signal between sets of electrode-contacts to generate dynamically shaped voltage gradients to modulate a specific set of properties in the biological tissue. A method of analysis for the recorded electric and magnetic field potentials is purposed to optimize the shape of the voltage-gradient geometry through modulation of the waveform signal that is sent through the dual-modal electrode-contacts.

An implantable medical device (IMD) configured to communicate with an external device (ED). The ED supports two way RF communications and has a light source. The IMD includes a processor coupled to an optical detector, the processor is configured to verify that light is being received from the ED light source and that the ED is a trusted device, establishing a unidirectional optical channel from the ED to the IMD. An RF transceiver is coupled to the processor, the processor being configured permit two way RF communications with the ED only under a condition that the ED is verified as a trusted device. The processor may be configure to wake up periodically or aperiodically to check for the presence of light from the ED light source. The processor may be configured to detect a multi-bit message from the ED via the unidirectional optical channel. The multi-bit message may include a key.

A system includes an interface assembly and electronic circuitry. The interface assembly is configured to receive DC power and a self-clocking differential signal comprising a data signal encoded with a clock signal at a clock frequency. The electronic circuitry is configured to recover, from the self-clocking differential signal, the data signal and the clock signal at the clock frequency, and to generate, based on the recovered clock signal at the clock frequency, a first synthesized clock signal at a first carrier frequency and a second synthesized clock signal at a second carrier frequency. The electronic circuitry is also configured to wirelessly transmit AC power and a data-modulated AC signal to an implantable stimulator implanted within a patient. The AC power is at the first carrier frequency and based on the DC power, while the data-modulated AC signal is at the second carrier frequency and based on the recovered data signal.

A bilateral hearing implant system has a left side and a right side. There is an interaural time delay (ITD) processing module on each side that adjusts ITD characteristics of the stimulation signals based on defined groups of stimulation channels that include: i. an apical channel group on each side corresponding to a lowest range of audio frequencies up to a common apical channel group upper frequency limit, wherein a common number of one or more stimulation channels is assigned to each apical channel group, and wherein corresponding apical channel group stimulation channels on each side have matching bands of audio frequencies, and ii. one or more basal channel groups on each side corresponding to higher range audio frequencies above the apical channel group upper frequency limit.

An apparatus for the control of a medical implant in a mammal body is provided. The apparatus comprises a first and a second part being adapted to be in electrical connection with each other by using said body as a conductor, in which apparatus the first part is adapted for implantation in the mammal body for the control of and communication with the medical implant, the second part is adapted to be worn on the outside of the mammal body in physical contact with said body and adapted to receive control commands from a user and to transmit these commands to the first part. The apparatus is adapted for communication between the first and the second parts and in that the second part is adapted to receive and recognize the control commands from a user transmitted to the first part for the control of said implant, the first part being adapted to convey such signals to the implant.

An example of a method embodiment may include receiving a user programmable neural stimulation (NS) dose for an intermittent neural stimulation (INS) therapy, and delivering the INS therapy with the user programmable NS dose to an autonomic neural target of a patient. Delivering the INS therapy may include delivering NS bursts, and delivering the NS bursts may include delivering a number of NS pulses per cardiac cycle during a portion of the cardiac cycles and not delivering NS pulses during a remaining portion of the cardiac cycles. The method may further include sensing cardiac events within the cardiac cycles, and controlling delivery of the user programmable NS dose of INS therapy using the sensed cardiac events to time delivery of the number of NS pulses per cardiac cycle to provide the user programmable NS dose. The user programmable NS dose may determine the number of NS pulses per cardiac cycle.

A leadless cardiac pacemaker (LCP) configured to sense cardiac activity and to pace a patient's heart. The LCP may include a housing, a first electrode secured relative to the housing, a second electrode secured relative to the housing, and a pressure sensor secured relative to the housing and coupled to the environment outside of the housing. The LCP may further include circuitry in the housing in communication with the first electrode, the second electrode, and the pressure sensor. The circuitry may be configured to determine and store a plurality of impedance-pressure data pairs, from which a representation of a pressure-volume loop may be determined.